Figure 1C.

Effects of rivastigmine, memantine and combinatory treatment on active avoidance testing in rats with scopolamine-impaired memory.

Abscissa – days of testing; Ordinate – number of intertrial crossings. *P<0.05 and **P<0.01 compared to respective day scopolamine group data;